102
Participants
Start Date
June 12, 2018
Primary Completion Date
October 18, 2023
Study Completion Date
October 18, 2023
ADRB2-genotype guided treatment
This intervention assesses whether ADRB2 genotype-guided treatment leads to better asthma control after 3 months compared to usual care in children who are uncontrolled despite adherent and adequate use of ICS.
Randomisation
In the control arm, children will be randomised over double dose ICS or ICS+LABA instead of treatment according to their genotype.
Universitair Ziekenhuis Antwerpen, Edegem
Nij Smellinghe, Drachten
Rijnstate, Arnhem
RadboudUMC, Nijmegen
Canisius Wilhelmina Ziekenhuis, Nijmegen
Amphia ziekenhuis, Breda
Catharina ziekenhuis, Eindhoven
VUmc locatie Boelelaan, Amsterdam
Academic Medical Center, Department of Respiratory Disease, Amsterdam-Zuidoost
Spaarne Gasthuis, Hoofddorp
Medisch Centrum Leeuwarden, Leeuwarden
Reinier de Graaf Gasthuis, Delft
Erasmus Medical Center, Rotterdam
Sint Franciscus Gasthuis, Rotterdam
Maasstadziekenhuis, Rotterdam
Haga ziekenhuis, The Hague
Medisch Spectrum Twente, Enschede
University Medical Center Groningen, Groningen
Martini ziekenhuis, Groningen
Tergooi ziekenhuis, Hilversum
Kinderspital, Zurich
Dutch Lung Foundation
UNKNOWN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER